Ð¢Ð°Ð·Ð¾Ð²Ð°Ñ Ñ…Ð¸Ñ€ÑƒÑ€Ð³Ð¸Ñ Ð¸ онкологиÑ
Published by ABV-press Publishing house (Journal Finder)
ISSN : 2686-9594 eISSN : 2686-9594
Abbreviation : Tazovaja hir. onkol.
Aims & Scope
Ð¢Ð°Ð·Ð¾Ð²Ð°Ñ Ñ…Ð¸Ñ€ÑƒÑ€Ð³Ð¸Ñ Ð¸ Ð¾Ð½ÐºÐ¾Ð»Ð¾Ð³Ð¸Ñ publishes research in: colorectal cancer, colon cancer, rectal cancer, anal cancer, local rectal cancer. View Aims & ScopeAbstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology and Medicine, ensuring accessibility and quality in research dissemination.
This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Role of human microbiota in the development of colorectal cancer
Citation: 8
Authors: S. O., S. S., Z. Z.
-
Endoscopic treatment for chronic radiation proctitis
Citation: 5
Authors: E. A., K. V., I. Yu., N. A., L. V., Ð. V.
-
“Watch and wait†strategy (active dynamic follow-up) in the management of rectal cancer patients with a complete clinical response
Citation: 4
Authors: Z. A., Dzh. Kh., Z. Z., V. A., S. S., V. S.
-
The optimal surgical volume for anorectal melanoma: a retrospective analysis of the Russian Colorectal Cancer Society registry
Citation: 4
Authors: S. S., E. G., A. M., V. B., K. A., D. V., Z. Z., I. S.
-
Combined and expanded operations in patients with relapsed ovarian cancer and affected retroperitoneal lymph nodes
Citation: 3
Authors: Kh. I., S. O., V. V., A. S., O. A.
-
The safety of intracorporeal anastomoses after right colectomy during the learning curve
Citation: 3
Authors: P. V., I. I., D. Yu., N. V., A. V., D. A., L. I.
-
Risk factors for colorectal anastomotic leakage and preventive measures: a retrospective cohort study
Citation: 3
Authors: M. S., S. S., E. V., M. D., Z. Z., S. G., V. Yu.
-
Quality of life of patients with rectal cancer after surgical treatment
Citation: 2
Authors: A. A., A. V., V. V., S. M., S. I.
-
Toxicity and efficacy of biosimilar bevacizumab in the second-line therapy for metastatic colon cancer in routine clinical practice: results of an independent observational study
Citation: 2
Authors: M.   Yu., F.   V., M.   A., V.  N., V.  V., A.  V., E.  S., O.  Yu., V.   A., N.  Kh., A.  A., E.   O., R.   R., O.  A., L.  V., S.  P., O.   A., S.  A., A.  A.